Monthly Archives: February 2012

Saving lives, one organ at a time: psychologists suggest ways to remove barriers to donation

Surveys unfailingly find that while most Americans express their interest in donating their organs and tissues, misperceptions about the donation process keep them from doing so, according to a new study appearing in the December 2011 APA Monitor.  For example, 52% of survey respondents said they feared physicians would not try as hard to save [Sign in to read the full article...]

New study suggests race plays a role in black’s access to a kidney transplant; evaluation, referral, waiting list processes often slower

An analysis of more than 2,200 patients treated at Emory University Transplant Center in Atlanta, GA, showed marked racial disparities in access to referral, transplant evaluation, waitlisting, and eventual transplant, according to a study conducted by Rachel Patzer, PhD, of Emory University and colleagues.  Of those, 64.9% were black, 57.3% were male, 33.6% lived in [Sign in to read the full article...]

New Jersey residents who choose to be a live donor could get financial break

Legislation working its way through the New Jersey state Senate would give residents considering becoming live kidney donors a financial incentive to help them  make their decision.  Senator Fred Madden, chair of the Senate Health Committee, has introduced a bill that would allow a tax deduction of up to $10,000 in gross income for organ [Sign in to read the full article...]

Artificial testicle built in a lab using stem cells could allow infertile men to conceive children

Researchers in California hope to become the first in the world to build an artificial testicle that produces human sperm that would allow infertile men to conceive children.  While recent studies have shown it’s possible to treat infertile male mice by producing sperm using stem cells from the mouse, the same has not been done [Sign in to read the full article...]

Chinese Ministry of Health announces it will stop all stem cell tourism

The Ministry of Health in China announced in mid-January that the country has stopped all unproven and experimental stem-cell treatment programs and refuse to accept any new applications  for approval of stem cell treatments, according to the International Medical Travel Journal (IMTJ). The instant ban on unapproved stem cell treatment will affect some US patients, [Sign in to read the full article...]